Clinical ResearchResearch compound

CJC‑1295 / Ipamorelin

GHRH analog + selective ghrelin mimetic combo for synergistic GH pulse

Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

CJC-1295 / Ipamorelin vial

WHAT IS CJC-1295 / IPAMORELIN?

Detailed overview

CJC-1295 (a modified GHRH 1-29) combined with Ipamorelin (a selective GHRP / ghrelin-receptor agonist) amplifies pulsatile growth hormone (GH) release through two different receptors, the classic "GHRH + GHRP" stack. CJC-1295 acts on pituitary GHRH receptors; ipamorelin acts on the ghrelin receptor. Their signals synergise, and ipamorelin's selectivity keeps cortisol/prolactin rises minimal.

Type

GHRH + GHRP combo

Structure

CJC-1295 (30 aa) + Ipamorelin (5 aa)

Molecular weight

~3367 + ~712 Da

Target area

Pulsatile GH increase (IGF-1)

Storage

2–8°C (reconstituted)

Stability

25–30 days (reconstituted)

Growth hormone release

The peptide acts on pituitary GHRH or GHS receptors, producing a **physiological, pulsatile GH release**, unlike synthetic rHGH, which keeps levels flat and leads to desensitization. IGF-1 rises into the upper-normal range, driving recovery, muscle protein synthesis, lipolysis and skin quality. Deep-sleep phases lengthen; collagen and bone-matrix synthesis activate. The effect is reversible and does not suppress the endogenous GH axis.

Composition

This stack contains the following peptides

Data console

Lab data

/lab/molecular-data.jsonLIVE
> ClassificationGHRH + GHRP combo
> StructureCJC-1295 (30 aa) + Ipamorelin (5 aa)
> Molecular weight~3367 + ~712 Da
> Target areaPulsatile GH increase (IGF-1)
> Storage2–8°C (reconstituted)
> Stability25–30 days (reconstituted)

Research indications

Investigated uses and mechanisms

Growth hormone release

Mimics physiological pulsatile GH secretion; IGF-1 rise.

Recovery & body comp

Muscle mass gain, fat reduction, post-workout recovery.

Sleep quality

Deep-sleep (N3) phases lengthen.

Reconstitution

How to prepare, step by step

Important

Sterile technique required. Use bacteriostatic water (BAC) only. Never distilled or tap water.

  1. 01

    Remove the vial and bacteriostatic water (BAC) from refrigeration; let them reach room temp for 5 minutes.

  2. 02

    Wipe both vial stoppers with an alcohol swab.

  3. 03

    Draw 2 ml of BAC water into a sterile syringe (typical for the 5 mg vial).

  4. 04

    Inject slowly down the side of the vial, do NOT spray directly onto the peptide powder.

  5. 05

    Swirl gently in a circular motion until dissolved (~30 s), do not shake.

  6. 06

    Wait for the solution to become clear. If sediment or discoloration appears, discard it.

  7. 07

    Label the vial with reconstitution date and concentration.

  8. 08

    Store at 2–8 °C, protected from light. Inspect visually before each use.

Quality indicators

How to recognize a pure peptide

Purity markers

3
  • Clear oil

    Clear or slightly yellow (MCT/sesame/castor oil), particle-free.

  • Vial integrity

    Glass intact, rubber stopper undamaged, aluminum crimp tight.

  • Label + COA

    Manufacturer + LOT + expiry legible; independent HPLC analysis on active content.

Use caution

1
  • BA/BB carrier blend

    Excessive benzyl alcohol (>3%) raises PIP risk; verify with UGL manufacturers.

Do not use

2
  • Cloudiness / sediment

    Floating particles, cloudiness, or sediment = HARD NO.

  • Damaged glass / stopper

    Cracked vial or loose stopper, sterility compromised.

Interactions & stacks

What to combine and what to avoid

CJC-1295

Synergistic

GHRH analog: sustained growth hormone stimulation

Ipamorelin

Synergistic

Selective GH secretagogue: without cortisol elevation

Ipamorelin

Synergistic

GHRH + GHRP, classic pulsatile GH stack.

Vitamin C / Zinc / B-complex

Synergistic

Supports collagen synthesis and antioxidant capacity.

Caffeine

Requires timing

Compatible with morning dosing; avoid late-day stacking.

Insulin

Use caution

Continuous glucose monitoring required.

NSAIDs (Ibuprofen, ASA)

Use caution

Long-term concurrent use may blunt regenerative effects.

Alcohol

Avoid

Reduces recovery and increases side-effect risk.

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Water retention, mild edema
  • Wrist / joint stiffness (carpal-tunnel-like)
  • Transient blood-glucose increase
  • Mild prolactin / cortisol increase (some peptides)
  • PIP (post-injection pain) – especially propionate, trenbolone-ace, or high-BA blends
  • Injection-site reaction: lumps, redness, warmth, tenderness

Contraindications · 5

  • Pregnancy and breastfeeding
  • Active malignancy
  • Known allergy to the peptide or its components
  • Severe hepatic or renal impairment (medical consultation required)
  • Age under 18

Related Peptides

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about CJC‑1295 / Ipamorelin?

Reach out to an advisor on Telegram. We can help you find the right peptide.

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: June 2, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.